Council seizes unsafe disposable e-cigarettes from retailer.

Sep.07.2022

400 mislabeled disposable e-cigarettes seized by Milton Keynes City Council due to safety concerns.

The Milton Keynes City Council confiscated 400 mislabeled disposable electronic cigarettes from a shop in Bletchley due to safety concerns.

The Trade Standards Subcommittee of the committee seized products with an estimated retail value of over £4000.

Legally speaking, the capacity of a disposable e-cigarette can only be 2ml or 600 puffs. The seized goods were 12ml, equivalent to 2400 cigarettes.

Statement

This article is compiled from third-party information and is intended for industry discussion and learning purposes.

This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the content. This article's translation is only intended for industry communication and research purposes.

Due to limitations in the quality of translation, the compiled article may not fully capture the same meaning as the original text. Therefore, it is best to refer to the original article as the definitive source.

2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or foreign expressions and positions.

The compilation of information in this article belongs to the original media and authors. If there is any infringement, please contact us for removal.

#North America #United States #Open system e-cigarettes #Technology.#E-cigarette #E-cigarettes and Tobacco #Retail store

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

South Korea Again Delays Tobacco Business Act Amendment on Synthetic Nicotine

South Korea’s amendment to the Tobacco Business Act, which would classify synthetic nicotine vapes and vape liquids as “tobacco” for regulatory and taxation purposes, has been delayed once again. Despite the government stressing its urgency due to youth access and risks of illicit drug mixing, both ruling and opposition parties at the Legislation and Judiciary Committee meeting agreed that the bill requires further discussion.

Nov.13 by 2FIRSTS.ai

KT&G Q3 Net Profit Up 73%; Overseas NGP Revenue Nearly Doubles, Nicotine Pouch Expansion Set to Launch Globally

KT&G reported its Q3 2025 financial results, posting revenue of KRW 1.83 trillion (≈USD 1.31 billion) and a 73.4% year-over-year surge in net profit—marking the company’s highest operating profit in five years. The Next Generation Product (NGP) segment performed strongly, generating KRW 279.1 billion (≈USD 199 million) in revenue, with overseas NGP sales more than doubling year-over-year.

Nov.06

Breaking News | FDA Adds on! Plus Nicotine Pouches to PMTA-Authorized List

The U.S. Food and Drug Administration (FDA) has added ON! Plus nicotine pouch products to its list of authorized products, disclosing that the brand has received Marketing Granted Orders (MGO) through the Premarket Tobacco Product Application (PMTA) pathway. The update makes on! Plus the second nicotine pouch brand authorized via PMTA, following ZYN. As of publication, the FDA had not issued a separate press release on the decision.

News

Dec.20

CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches

CSUR—the Research Institute Supporting Juul and NJOY’s successful PMTAs—assessed FDA’s pilot for nicotine pouches. The program expedites premarket review by deferring behavioral data to post-market reporting. CSUR says this could speed authorizations, but manufacturers must still produce behavioral and real-world evidence after a Marketing Granted Order to maintain compliance with public-health standards.